Personalized blood thinner dosing may reduce bleeding risk in heart patients awaiting surgery
NCT ID NCT07225842
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adjusting the dose of the blood thinner cangrelor based on individual test results can better control clotting in people with coronary artery disease who are waiting for surgery. About 50 adults will receive either a standard or tailored dose to find the safest and most effective approach. The goal is to reduce the risk of both blood clots and bleeding during the bridging period before surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida Jacksonville
RECRUITINGJacksonville, Florida, 32209, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Can a new heart pump outperform the standard during High-Risk angioplasty?
- AI reads blood flow to predict if heart stents will work
- Scoring balloon aims to crack tough heart plaques for better stent fit
- New balloon tackles tough heart blockages in major registry
- Video lessons boost heart rehab at home, study finds